Edition:
United States

CAS Medical Systems Inc (CASM.OQ)

CASM.OQ on NASDAQ Stock Exchange Capital Market

0.63USD
15 Dec 2017
Change (% chg)

$0.01 (+0.90%)
Prev Close
$0.62
Open
$0.63
Day's High
$0.65
Day's Low
$0.61
Volume
4,262
Avg. Vol
17,518
52-wk High
$1.75
52-wk Low
$0.59

Latest Key Developments (Source: Significant Developments)

‍Long Focus Capital Management Reports 6.9 Pct Passive Stake In CAS Medical Systems
Friday, 1 Dec 2017 04:15pm EST 

Dec 1 (Reuters) - Cas Medical Systems Inc ::‍LONG FOCUS CAPITAL MANAGEMENT LLC REPORTS 6.9 PERCENT PASSIVE STAKE IN CAS MEDICAL SYSTEMS INC ​AS OF NOVEMBER 29 - SEC FILING.  Full Article

CASMED reports Q3 earnings per share $0.10
Thursday, 9 Nov 2017 08:00am EST 

Nov 9 (Reuters) - Cas Medical Systems Inc :CASMED reports third-quarter 2017 financial results.Q3 earnings per share $0.10.Q3 sales $4.5 million versus $5.0 million.Cas Medical Systems Inc sees 2017 ‍total fore-sight oximetry sales to be flat to down slightly​.Cas Medical Systems Inc sees 2017 ‍total fore-sight sensor sales to increase in low single-digit percentages​.Cas Medical Systems Inc - ‍Company affirmed its financial guidance for 2017​.Cas Medical Systems Inc - "‍We are continuing on a path to cash flow breakeven, which we expect to reach in early 2019​".  Full Article

CAS Medical Systems Q2 loss per share $0.09
Tuesday, 8 Aug 2017 08:37am EDT 

Aug 8 (Reuters) - Cas Medical Systems Inc :CASMED reports second-quarter 2017 financial results.Q2 loss per share $0.09.Q2 sales $4.6 million.Revises full-year financial guidance​.Sees ‍2017 total fore-sight oximetry sales to be flat to down slightly​.Sees ‍2017 total fore-sight sensor sales to increase in low single-digit percentages​.  Full Article

Casmed sells non-invasive blood pressure monitoring product line to Suntech Medical
Wednesday, 26 Jul 2017 08:00am EDT 

July 26 (Reuters) - CAS Medical Systems Inc ::Casmed sells non-invasive blood pressure monitoring product line to Suntech Medical.Deal for $4.5 million in cash.  Full Article

Casmed reports Q1 loss per share of $0.08
Wednesday, 3 May 2017 08:00am EDT 

May 3 (Reuters) - Cas Medical Systems Inc :Casmed reports first-quarter 2017 financial results.Q1 loss per share $0.08.Q1 sales $5.2 million versus $5.5 million.Sees 2017 total fore-sight sales to increase in mid-single-digit percentages.Sees 2017 total fore-sight disposable sensor sales to increase approximately 10 pct.Sees 2017 U.S. Fore-Sight sensor sales to increase in mid-teens percentages.Sees 2017 U.S. Monitor placements to increase in mid-teens percentages.  Full Article

Thomas Patton reports 5.6 pct stake in CAS Medical Systems Inc
Tuesday, 4 Apr 2017 07:35am EDT 

Cas Medical Systems Inc :Thomas M. Patton reports 5.6 percent stake in CAS Medical Systems Inc, as of March 10, 2017 - SEC filing.  Full Article

CAS Medical Q4 loss per share $0.07
Thursday, 9 Mar 2017 08:00am EST 

CAS Medical Systems Inc : Casmed reports 2016 fourth-quarter and full-year financial results . Q4 loss per share $0.07 . Q4 sales rose 3 percent to $5.5 million .CAS Medical Systems Inc - expecting 2017 total fore-sight sales increasing in mid-teen percentages.  Full Article

Norman Pessin reports 5 pct stake in CAS Medical Systems
Wednesday, 4 Jan 2017 10:51am EST 

Cas Medical Systems Inc : Norman Pessin reports 5.0 percent stake in CAS Medical Systems Inc as of Jan 3 - sec filing .Norman Pessin had previously reported a stake of 4.0 percent in CAS Medical Systems Inc as of Nov 6, 2015.  Full Article

CASMED Q2 loss per share $0.08
Thursday, 4 Aug 2016 08:00am EDT 

Cas Medical Systems Inc : Q2 loss per share $0.08 . Q2 sales rose 18 percent to $5.5 million . Affirming expectation to ship a total of 400 fore-sight cerebral oximeters this year .Also on track to achieve our 2016 growth objective of fore-sight sales exceeding 20 percent.  Full Article

CAS Medical Systems says entered loan agreement with Solar Capital
Tuesday, 5 Jul 2016 06:45am EDT 

CAS Medical Systems Inc : Says entered into a loan and security agreement with Solar Capital Ltd - SEC filing . Says lenders are providing company with a 48-month secured term loan in the amount of $8 million . Says lenders are providing company with revolving loan in the maximum amount of $2.5 million .Says revolver expires on July 1, 2018 and the term loan matures on July 1, 2020.  Full Article

BRIEF-‍Long Focus Capital Management Reports 6.9 Pct Passive Stake In CAS Medical Systems

* ‍LONG FOCUS CAPITAL MANAGEMENT LLC REPORTS 6.9 PERCENT PASSIVE STAKE IN CAS MEDICAL SYSTEMS INC ​AS OF NOVEMBER 29 - SEC FILING Source text: (http://bit.ly/2kjeuz3) Further company coverage: